US Stocks
/
Palisade Bio, Inc. Share Price

Palisade Bio, Inc. Share Price

NASDAQ: PALI | Micro Cap
$2.10
-$0.03 (-1.41%) Last updated on 07 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Palisade Bio, Inc. Stock Performance

Open
$2.09
Prev. Close
$2.13
Circuit Range
N/A
Day Range
$2.08 - $2.15
Year Range
$0.53 - $2.85
Volume
49,752
Average Traded
$2.10

Palisade Bio, Inc. Share Price Today

As of 9 August 2026, Palisade Bio, Inc.'s share price is $2.10. The stock opened at $2.09, compared to its previous close of $2.13. During today's trading session, Palisade Bio, Inc.'s share price traded between $2.08 and $2.15, with an average price of $2.12. Over the past 52 weeks, the stock has recorded a high of $2.85 and a low of $0.53. In terms of performance, Palisade Bio, Inc.'s share price has risen by 18.03% over the last six months and is up 210.83% on a year-on-year basis.

Palisade Bio, Inc. Share Price Chart

$2.08$2.15
L
Show Current Price
H

Palisade Bio, Inc. Stock Fundamentals & Key Indicators

Market Cap
$116.63M
PE Ratio (TTM)
-6.98
Dividend Yield
N/A
EPS (TTM)
$-0.30
Revenue (TTM)
N/A
Return On Equity (TTM)
-12.97%
Profit Margin
N/A
Debt to Equity
0.04
Quarterly Earnings Growth YoY
N/A

Palisade Bio, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024
Revenue$0.00$0.00$0.00
Net Profit-$3.53M-$4.08M-$3.49M
Net Profit MarginN/AN/AN/A
Income ChangeN/A-15.68%14.53%

Palisade Bio, Inc. Annual Profit & Loss

All figures in USD

Particulars20232024
Revenue$250000.00$0.00
Net Profit-$12.30M-$14.44M
Net Profit Margin-4920.00%N/A
Income ChangeN/A-17.38%

About Palisade Bio, Inc.

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.

Palisade Bio, Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$1.90
$2.10
+10.55%
Jul 2026
$2.13
$1.90
-10.19%
Jun 2026
$2.12
$2.11
-0.94%
May 2026
$1.97
$2.13
+7.04%
Apr 2026
$1.76
$1.99
+13.71%
Mar 2026
$1.75
$1.75
-1.41%
Feb 2026
$1.49
$1.77
+18.33%
Jan 2026
$2.40
$1.50
-36.44%
Dec 2025
$2.03
$2.36
+12.11%
Nov 2025
$1.99
$2.10
+2.18%
Oct 2025
$1.04
$2.06
+144.37%
Sep 2025
$0.66
$0.84
+25.07%

PALI Share Price FAQs

What is Palisade Bio, Inc. share price today?

chevron-up
Palisade Bio, Inc. share price today is $2.10 as on August 7, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Palisade Bio, Inc. stock?

chevron-up
The 52 week high of Palisade Bio, Inc. stock is $2.85, while the 52 week low is $0.53 as of 7 Aug '26.

What is PALI's market capitalisation today?

chevron-up
PALI market capitalisation is $116.63M as of August 9, 2026, at 12:14 pm IST.

What is PALI's net income for the last quarter?

chevron-up
PALI's net income for the last quarter is -0.00B USD.

What is the 5 year returns of PALI?

chevron-up
The 5 year returns of PALI is -99.90% as on 7 Aug '26.

What is the high & low stock price of PALI today?

chevron-up
PALI stock price hit a high of $2.15 and low of $2.08 as of 7 Aug '26.

Can I buy PALI shares in India?

chevron-up
Yes. You can buy PALI in India by opening an international trading account.